In Ex parte Michalek, Attraction No. 2023-004204 (PTAB Dec. 27, 2024), the Patent Trial and Attraction Board (PTAB) evaluated an invention involving medical well being know-how and synthetic intelligence. The PTAB particularly acknowledged that the patent claims at subject recited new details about the nexus between sure biomarkers and improvement of lung most cancers as facilitated by machine studying. In truth, previous to enchantment, the applicant had efficiently overcome all rejections below part 103. However, primarily based on Patent Workplace steering, the PTAB nonetheless decided the claims had been flawed from the attitude of material eligibility. Though the details on this resolution concern medical well being innovation, the choice is useful to tell patent technique for AI enabled innovations throughout varied disciplines and industries.
Trending
- FTC Locks In Omnicom–IPG Deal With Stricter Ad Rules
- Google Ads tweaks default conversion goal behavior
- DJI launches hands-free wearable Osmo Nano
- Kitchen sink drama: Trump’s latest tariffs leave experts scratching heads | Tariffs
- Umm…you can get a laser engraver for just $279 right now
- What’s behind the massive AI data center headlines?
- Bosch to cut 13,000 jobs in Germany to save billions in costs
- Have you heard? KSI’s got talent, British networks take on Ms. Rachel, and sorority girls make six figures.